Clinical Report: More Than Nerves: Rethinking NK Pathology
Overview
Recent findings indicate that neurotrophic keratitis (NK) is a complex ocular surface disease involving not only corneal denervation but also significant limbal stem cell deficiency and immune dysregulation. The study highlights the interconnectedness of these factors and the potential for targeted therapies to improve outcomes.
Background
Neurotrophic keratitis (NK) has traditionally been viewed as a consequence of corneal nerve damage, leading to epithelial breakdown. However, emerging evidence suggests that limbal stem cell deficiency (LSCD) and immune activation are integral components of NK pathology. Understanding these relationships is crucial for developing effective treatment strategies.
Data Highlights
| Parameter | NK Patients | Healthy Controls |
|---|---|---|
| Corneal Nerve Fiber Density | Reduced | Normal |
| LESC Density | ~50% reduction | Normal |
| DC Density | Increased | Normal |
Key Findings
- Profound corneal nerve loss and marked depletion of LESCs were observed in NK patients.
- Increased dendritic cell density and activation were noted, indicating chronic inflammation.
- LESC density correlated negatively with dendritic cell density and positively with corneal nerve parameters.
- Topical recombinant human nerve growth factor (rhNGF) improved LESC density and reduced inflammation before nerve regeneration.
- Corneal nerve and LESC parameters did not fully normalize after rhNGF treatment, indicating partial restoration.
Clinical Implications
Clinicians should consider the role of limbal stem cell health and immune status in managing NK, rather than focusing solely on corneal sensation. Early intervention with therapies like rhNGF may stabilize the ocular surface and promote recovery.
Conclusion
This study reframes NK as a multisystem disease, emphasizing the need for comprehensive assessment and management strategies that address nerve, stem cell, and immune interactions.
References
- Lasby, A., Contact Lens Spectrum, 2024 -- NK FROM A TO Z
- The Ophthalmologist, 2026 -- Why Early NK Treatment Matters
- Salinger, C., Ophthalmology Management, 2020 -- Neurotrophic keratitis: What's in the toolbox
- Association between Neurotrophic Keratitis and Limbal Stem Cell Deficiency - ScienceDirect
- Neurotrophic keratopathy: Update in diagnosis and management - PMC
- Brain — Rethinking Approaches to Amyotrophic Lateral Sclerosis
- Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy
- Association between Neurotrophic Keratitis and Limbal Stem Cell Deficiency - ScienceDirect
- Neurotrophic keratopathy: Update in diagnosis and management - PMC
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.